Skeletal-Related Events for Bone Metastases

TON Interview with the Innovators: Volume 1 - Genitourinary Cancers, Video
Angela Hunter, BSN
Pam Skurkay, RN, BSN, CPAN, CURN
Dianna Shafer, BSN, CURN, CPN, CPC-I
Pam Skurkay, Dianna Shafer, and Angela Hunter discuss the rates of incidences of this issue as well as the benefits of using Xgeva, including a better quality of life for patients.
Related Items
Questions About Treating Patients on a CDK4/6 Inhibitor
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
The Use of Chemotherapy in the Metastatic Setting
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
The Mechanism of Action of CDK4/6 Inhibitors
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer
Matthew P. Goetz, MD
Conference Correspondent  published on December 10, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
CDK4/6 Inhibitors vs Chemotherapy for Patients with Metastatic Breast Cancer
Hope S. Rugo, MD
Conference Correspondent  published on December 9, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?
Matthew P. Goetz, MD
Conference Correspondent  published on December 8, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Hot Topics at SABCS 2017
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
HER2+ Breast Cancer and CDK4/6 Inhibitors
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Progressing on a CDK4/6 Inhibitor plus an Aromatase Inhibitor
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
What Differentiates Abemaciclib, Ribociclib, and Palbociclib?
Hope S. Rugo, MD
Conference Correspondent  published on December 7, 2017 in SABCS 2017 - Breast Cancer, Breast Cancer, Video
Last modified: October 4, 2016